美股A股
StockGist
Back
6-K2026-04-30· grok-4-1-fast-non-reasoning

AAPG · ASCENTAGE PHARMA GROUP INTERNATIONAL

0001213900-26-050581

SEC filing

Summary

Ascentage Pharma Group International announced its 2026 AGM to approve director re-elections, auditor re-appointment, 20% share issuance and 10% repurchase mandates, and adoption of amended memorandum and articles enabling hybrid/electronic meetings.

Key takeaways